Skip to main content
logo
Kobo Biotech Limited (BOM:531541)
India flag India · Delayed Price · Currency is INR
4.860
+0.230 (4.97%)
At close: Aug 21, 2026

Kobo Biotech Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Revenue
------
Revenue Growth
------
Gross Profit
-0-0---352.38-
Operating Income
-51.31-51.31-48.98-50.18-178.79-78.43
Net Income
-52.3-52.3-49.29-55.53-152.26-192.31
Earnings Per Share
-2.20-2.20-2.07-2.33-6.39-8.07
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Cash & Investments
43.5643.561.811.271.2615.6
Total Debt
1,3971,3971,3971,3981,4072,605
Net Cash (Debt)
-1,353-1,353-1,395-1,397-1,406-2,590
Net Cash Growth
------
Net Cash Per Share
-56.80-56.80-58.56-58.64-59.01-108.70

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Operating Cash Flow
41.7541.752.048.75937.5725.09
Capital Expenditures
------
Free Cash Flow
41.7541.752.048.75937.5725.09
Free Cash Flow Growth
443.15%1950.69%-76.72%-99.07%3636.53%-82.66%

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
P/FCF Ratio
2.771.8044.475.180.147.03
PS Ratio
------